E-LIB Suche - Ergebnisse für: Gargaun, E.

1

DMD – BIOMARKERS & OUTCOME MEASURES:

Gargaun, E. ; Bassez, G. ; Wahbi, K....
Neuromuscular Disorders. 30 (2020) - p. S81 , 2020

Link: https://doi.org/10.1016/..

2

P.335Phenotypic and genomic characterization as predictors ..:

Gargaun, E. ; Wahbi, K. ; Ben Yaou, R....
Neuromuscular Disorders. 29 (2019) - p. S165 , 2019

Link: https://doi.org/10.1016/..

3

SMA CLINICAL DATA, OUTCOME MEASURES AND REGISTRIES:

Hogrel, J. ; Annoussamy, M. ; Chabanon, A....
Neuromuscular Disorders. 28 (2018) - p. S56 , 2018

Link: https://doi.org/10.1016/..

4

Longitudinal data of the European prospective natural histo..:

Chabanon, A. ; Annoussamy, M. ; Daron, A....
Neuromuscular Disorders. 27 (2017) - p. S134 , 2017

Link: https://doi.org/10.1016/..

5

Associations between NMR, electrophysiological, strength an..:

Hogrel, J. ; Annoussamy, M. ; Chabanon, A....
Neuromuscular Disorders. 27 (2017) - p. S224-S225 , 2017

Link: https://doi.org/10.1016/..

6

Longitudinal data of patients with myotubular myopathy enro..:

Annoussamy, M. ; Lilien, C. ; Gidaro, T....
Neuromuscular Disorders. 27 (2017) - p. S170 , 2017

Link: https://doi.org/10.1016/..

7

Innovative home activity monitoring in non-ambulant patient..:

Gargaun, E. ; Seferian, A. ; Quicke, G....
Neuromuscular Disorders. 27 (2017) - p. S225 , 2017

Link: https://doi.org/10.1016/..

8

Safety, tolerability and clinical efficacy of nusinersen in..:

Aragon-Gawinska, K. ; Gargaun, E. ; Seferian, A....
Neuromuscular Disorders. 27 (2017) - p. S211 , 2017

Link: https://doi.org/10.1016/..

9

First experience of Nusinersen early access program in pati..:

Gargaun, E. ; Aragon-Gawinska, K. ; Seferian, A....
Neuromuscular Disorders. 27 (2017) - p. S211-S212 , 2017

Link: https://doi.org/10.1016/..

10

Longitudinal home-monitoring data in non-ambulant patients ..:

Seferian, A. ; Quicke, G. ; Gargaun, E....
Neuromuscular Disorders. 27 (2017) - p. S235 , 2017

Link: https://doi.org/10.1016/..

11

New myotubular myopathy classification:

Lilien, C. ; Annoussamy, M. ; Gidaro, T....
Neuromuscular Disorders. 27 (2017) - p. S169 , 2017

Link: https://doi.org/10.1016/..

12

Movement monitoring at home and during study visits identif..:

Servais, L. ; Grelet, M. ; Seferian, A....
Neuromuscular Disorders. 26 (2016) - p. S152-S153 , 2016

Link: https://doi.org/10.1016/..

13

Feasibility of magneto-inertial motion analysis in non-ambu..:

Seferian, A. ; Quicke, G. ; Gidaro, T....
Neuromuscular Disorders. 26 (2016) - p. S102 , 2016

Link: https://doi.org/10.1016/..

14

Longitudinal results of magneto-inertial motion analysis in..:

Seferian, A. ; Gargaun, E. ; Grelet, M....
Neuromuscular Disorders. 26 (2016) - p. S184-S185 , 2016

Link: https://doi.org/10.1016/..

15

Baseline data from patients with myotubular myopathy enroll..:

Annoussamy, M. ; Lilien, C. ; Gidaro, T....
Neuromuscular Disorders. 26 (2016) - p. S116-S117 , 2016

Link: https://doi.org/10.1016/..